What medicines does Mengxin Pharmaceutical have?
As a company focused on pharmaceutical R&D and production, Mengxin Pharmaceutical's products cover multiple therapeutic areas, including anti-tumor, cardiovascular, and anti-infection. The following will introduce in detail the main drugs of Mengxin Pharmaceutical and their related information.
1. Classification of popular drugs of Mengxin Pharmaceutical

| Drug category | Representative medicine | Indications |
|---|---|---|
| antineoplastic drugs | Gemcitabine hydrochloride for injection | Non-small cell lung cancer, breast cancer, etc. |
| cardiovascular drugs | Atorvastatin calcium tablets | hypercholesterolemia |
| anti-infective drugs | Cefixime capsules | Respiratory tract infections, urinary tract infections, etc. |
| Digestive system medicine | Omeprazole enteric coated capsules | Gastric ulcer, reflux esophagitis |
2. Detailed introduction of Mengxin Pharmaceutical’s core drugs
1.Gemcitabine hydrochloride for injection
This drug is Mengxin Pharmaceutical’s main anti-tumor product and is mainly used to treat malignant tumors such as non-small cell lung cancer and breast cancer. It effectively delays tumor progression by inhibiting DNA synthesis.
2.Atorvastatin calcium tablets
As a commonly used drug in the cardiovascular field, atorvastatin calcium tablets can significantly reduce low-density lipoprotein cholesterol levels and are suitable for patients with hypercholesterolemia.
3.Cefixime capsules
It belongs to the third generation cephalosporin antibiotics and is effective against a variety of bacterial infections. It is commonly used in clinical treatment of respiratory tract, urinary tract and other infections.
3. Drug production and quality of Mengxin Pharmaceutical
| Drug name | Dosage form | Specifications | Approval number |
|---|---|---|---|
| Gemcitabine hydrochloride for injection | Lyophilized powder injection | 1g | National drug approval number H2005**** |
| Atorvastatin calcium tablets | tablet | 10mg | National drug approval number H2010**** |
| Cefixime capsules | capsule | 100mg | National drug approval number H2008**** |
4. Mengxin Pharmaceutical R&D Trends
In recent years, Mengxin Pharmaceutical has continued to increase investment in research and development and made breakthroughs in the fields of anti-tumor and biosimilar drugs. Its independently developed PD-1 monoclonal antibody has entered Phase III clinical trials and is expected to provide new treatment options for cancer patients.
5. Drug purchase and medication suggestions
Mengxin Pharmaceutical's drugs are all sold through formal channels, and patients need to purchase them with a doctor's prescription. When taking medication, you must strictly follow the doctor's instructions and pay attention to adverse drug reactions and contraindications.
The above is a detailed introduction to Mengxin Pharmaceutical’s main drugs. For more information, you can consult a professional physician or log on to the website of the State Food and Drug Administration.
check the details
check the details